Overview
Announcements

Ordinary Rebalance | Solactive Obesity Index | Effective Date 1st August 2023

In the ordinary rebalance, the following index composition will be implemented effective open 01.08.2023:

MICROPORT SCIENTIFIC CORP
I-SENS INC
LIFETECH SCIENTIFIC CORP
SD BIOSENSOR INC
NOVAREX CO LTD
SELVAS HEALTHCARE INC
HUA MEDICINE
OK BIOTECH CO LTD
TAIDOC TECHNOLOGY CORP
BIONIME CORP
NIPRO (NISSHO) CORP ORD
TCI CO LTD
ADAPTHEALTH CORP
ALTIMMUNE INC
ANGIODYNAMICS INC
ARTIVION INC
N BROWN GROUP PLC
CATO CORP-CLASS A
CVRX INC
DARIOHEALTH CORP
DEXCOM INC
EKF DIAGNOSTICS HOLDINGS PLC
ESPERION THERAPEUTICS INC
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
HERBALIFE LTD
INSPIRE MEDICAL SYSTEMS INC
IRHYTHM TECHNOLOGIES INC
LEMAITRE VASCULAR INC
LEXICON PHARMACEUTICALS INC
MADRIGAL PHARMACEUTICALS INC
MEDIFAST INC
MANNKIND CORP
NOVO NORDISK A/S
ORAMED PHARMACEUTICALS INC
INSULET CORP
RESMED INC-CDI
RHYTHM PHARMACEUTICALS INC
SENSEONICS HOLDINGS INC
TEVA PHARMACEUTICAL IND LTD
TANDEM DIABETES CARE INC
USANA HEALTH SCIENCES INC
WW INTERNATIONAL INC